EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

HBV RNA Predicts the Risk of Off‐Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta‐Analysis

Dong-Hui Wang, Jia-Lan Wang, Su-Wen Jiang, Ai-Wu Zhou, Meng-Han Jin, Hao-Jin Zhang, Shi-Qi Yang, Shi-Yang Fan, Ai-Rong Hu

Journal of Viral Hepatitis · 2026-04 · 33 (4)

DOI: 10.1111/jvh.70167 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 13.03.2026. Verfasst von Dong-Hui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Liver Diseases Center, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, RNA, Viral, Antiviral Agents, Hepatitis B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Medical Scientific Research Foundation of China National Health Commission-Zhejiang Province, Ningbo Medical & Health Brand Discipline, Ningbo Public Welfare Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since there are currently few antiviral drugs that can effectively reduce hepatitis B surface antigen levels, the recurrence rate remains high in patients with chronic hepatitis B (CHB) after discontinuing nucleoside analogues (NAs) treatment. This study aims to provide recommendations for monitoring relapse after treatment cessation, while also elucidating the significance of HBV RNA in predicting relapse in CHB patients. Studies published between 2019 and 2025 were searched using PubMed, Embase, Web of Science, Cochrane Library, CNKI, Wanfang, and Cqvip. There are 21 cohort studies included and 2043 individuals involved. In our study, HBV RNA‐positive individuals had a 1.9‐fold higher viral relapse (VR) rate and a 2.26‐fold higher clinical relapse (CR) rate compared to negative patients (all p < 0.0001). Subgroup analyses indicated that HBeAg positive at baseline was associated with higher rates of CR ( p = 0.006) and no significant correlation between longer follow‐up period following the cessation of NAs therapy (≥ 2 years) and higher VR or CR. For each log10 copies/ml increase in HBV RNA levels at discontinuation, there was a 1.32‐fold increase in VR and a 1.37‐fold increase in CR (all p < 0.0001). Our findings evaluated the relationship between HBV RNA status and levels at the time of NAs discontinuation and post‐discontinuation relapse, highlighting HBV RNA as a helpful post‐treatment biomarker for predicting relapse. HBV RNA surveillance is essential for patients discontinuing therapy following NAs, particularly for those who are HBeAg‐positive at baseline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicRNA, ViralAntiviral AgentsHepatitis B virusHumansRecurrenceViral Load

Stichwörter der Autor:innen

HBV RNAchronic hepatitis Bclinical relapsenucleoside analoguesviral relapse

Substanzen

RNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Liver Diseases Center, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China.
  • Cixi Biomedical Research Institute, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
  • Ningbo University Health Science Center, Ningbo, Zhejiang Province, China.
  • School of Medicine, Shaoxing University, Shaoxing, Zhejiang Province, China.

Förderung

  • Major Medical Scientific Research Foundation of China National Health Commission-Zhejiang Province
  • Ningbo Medical & Health Brand Discipline
  • Ningbo Public Welfare Research Foundation
  • Zhejiang Province Key Clinical Specialty Construction Project

Zitieren

APA

Wang, D. H., Wang, J. L., Jiang, S. W., Zhou, A. W., Jin, M. H., Zhang, H. J., Yang, S. Q., Fan, S. Y., & Hu, A. R. (2026). HBV RNA Predicts the Risk of Off‐Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta‐Analysis. Journal of Viral Hepatitis, 33(4). https://doi.org/10.1111/jvh.70167

Vancouver

Wang DH, Wang JL, Jiang SW, Zhou AW, Jin MH, Zhang HJ, et al. HBV RNA Predicts the Risk of Off‐Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta‐Analysis. Journal of Viral Hepatitis. 2026;33(4). doi:10.1111/jvh.70167

BibTeX
@article{Wang2026,
  author = {Wang, Dong-Hui and Wang, Jia-Lan and Jiang, Su-Wen and Zhou, Ai-Wu and Jin, Meng-Han and Zhang, Hao-Jin and Yang, Shi-Qi and Fan, Shi-Yang and Hu, Ai-Rong},
  title = {HBV RNA Predicts the Risk of Off‐Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/jvh.70167}
}
Kostenlos starten →